跳至主要内容
临床试验/EUCTR2013-000338-37-DE
EUCTR2013-000338-37-DE进行中(未招募)1 期

Evaluation of the necessity of a pharmacological treatment with antipsychotics for the prevention of relapse in long-term stabilized schizophrenic patients: a randomized, single-blind, longitudinal trial

Technische Universität München, vertreten durch das Klinikum rechts der Isar0 个研究点目标入组 25 人开始时间: 2014年9月23日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Male or female patients, 18 to 65 years of age.
  • 2. Diagnosis of schizophrenia or schizoaffective disorder.
  • 3. The participants have to be in remission for at least 3 years (i.e. no psychiatric
  • hospitalisation) under a stable antipsychotic medication.
  • 4. Able to give informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 25
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Actively suicidal.
  • 2. Serious medical illnesses.
  • 3. Known non-complience concerning the medication.
  • 4. Medication with clozapin.
  • 5. Patients with substance dependence other than nicotine or caffeine within 6 months prior to baseline.
  • 6. Pregnancy.

研究者

发起方
Technische Universität München, vertreten durch das Klinikum rechts der Isar

相似试验